Grant: Discovery Grants Program - Individual
Université de Montréal
$52,000.00
Antimicrobial peptides from the microbiome as modulators of bacterial virulence
FY 2022-23
Summary
The gut microbiome has been intensively studied lately because of its fundamental role in human health. However, the molecular dialogue between the bacteria from the microbiome is still poorly understood. My research focus on understanding this dialogue in a cooperative or a competitive bacterial relationship. The bacteria from the microbiome are producing antimicrobial peptides (AMPs), which have an important role in regulating the microbial community. The aim of this proposal is to determine if AMPs produced by the microbiome can modulate the expression and secretion of proteins involved in virulence and resistance in V. cholerae. Therefore, our specific objectives are to: i) Identify and select bacteria from the microbiome that produce AMP(s) active against V. cholerae. Two approaches will be considered. A random approach consisting of the screening of a bacterial collection from the microbiome for their anti-Vibrio activity, followed by an identification of the producer and a purification of the AMPs. The second approach consist on the selection of the AMPs produced by bacteria from the microbiome based on the available literature, eventually followed by a cloning and purification.ii) Determine how the AMPs from the microbiome affect the expression and secretion of proteins from V. cholerae. A global proteomic approach will be performed to identify the protein differentially expressed in presence of AMPs. A construction of the mutants of the genes coding for the identified effectors will follow for the identification of the role of the effector proteins in antimicrobial peptide resistance and in virulence using animal models.iii) Identify the risk of developing a resistance to the AMPs from the microbiome, by cultivating different intestinal pathogens with low concentration of the AMPs from the microbiome.This work will greatly improve our knowledge of bacteria-bacteria communication in the gut at the molecular level. The novelty resides in considering AMPs as molecules that can subvert the signalling pathways of the neighbouring bacteria, including pathogens, therefore modulating their ability to adapt to their environment.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-05322
Name nom
Duperthuy, Marylise
Department département
Microbiologie, infectiologie et immunologie - Microbiologie, infectiologie et immunologie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2017
Award amount
52000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Installment
inst:6;7
Partie
2
Nb partie
7
Application title
Antimicrobial peptides from the microbiome as modulators of bacterial virulence
Application summary
The gut microbiome has been intensively studied lately because of its fundamental role in human health. However, the molecular dialogue between the bacteria from the microbiome is still poorly understood. My research focus on understanding this dialogue in a cooperative or a competitive bacterial relationship. The bacteria from the microbiome are producing antimicrobial peptides (AMPs), which have an important role in regulating the microbial community. The aim of this proposal is to determine if AMPs produced by the microbiome can modulate the expression and secretion of proteins involved in virulence and resistance in V. cholerae. Therefore, our specific objectives are to: i) Identify and select bacteria from the microbiome that produce AMP(s) active against V. cholerae. Two approaches will be considered. A random approach consisting of the screening of a bacterial collection from the microbiome for their anti-Vibrio activity, followed by an identification of the producer and a purification of the AMPs. The second approach consist on the selection of the AMPs produced by bacteria from the microbiome based on the available literature, eventually followed by a cloning and purification.ii) Determine how the AMPs from the microbiome affect the expression and secretion of proteins from V. cholerae. A global proteomic approach will be performed to identify the protein differentially expressed in presence of AMPs. A construction of the mutants of the genes coding for the identified effectors will follow for the identification of the role of the effector proteins in antimicrobial peptide resistance and in virulence using animal models.iii) Identify the risk of developing a resistance to the AMPs from the microbiome, by cultivating different intestinal pathogens with low concentration of the AMPs from the microbiome.This work will greatly improve our knowledge of bacteria-bacteria communication in the gut at the molecular level. The novelty resides in considering AMPs as molecules that can subvert the signalling pathways of the neighbouring bacteria, including pathogens, therefore modulating their ability to adapt to their environment.